zoledronic acid has been researched along with Focal Segmental Glomerulosclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Markowitz, GS; Perazella, MA | 1 |
Amico, P; Bodmer, M; Haschke, M; Krähenbühl, S; Kummer, O; Mayr, M; Mihatsch, MJ | 1 |
1 review(s) available for zoledronic acid and Focal Segmental Glomerulosclerosis
Article | Year |
---|---|
Bisphosphonate nephrotoxicity.
Topics: Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney Cortex Necrosis; Kidney Diseases; Pamidronate; Practice Guidelines as Topic; Zoledronic Acid | 2008 |
1 other study(ies) available for zoledronic acid and Focal Segmental Glomerulosclerosis
Article | Year |
---|---|
Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney; Male; Multiple Myeloma; Nephrotic Syndrome; Time Factors; Treatment Outcome; Zoledronic Acid | 2007 |